Evolocumab In Advanced Chronic Kidney Disease Trial
NCT04510844
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
loss of funding
Conditions
Chronic Kidney Diseases
High Cholesterol
Interventions
DRUG:
Evolocumab
OTHER:
Placebo
Sponsor
NYU Langone Health